In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

In the 1980s, Gram-negative pathogens appeared to have been beaten by oxyimino-
cephalosporins, carbapenems, and fluoroquinolones. Yet these pathogens have fought …

Abstract Objectives Infections caused by Klebsiella pneumoniae (Kp) carbapenemase
(KPC)-producing strains of Kp have become a significant threat in recent years. To assess …

Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in
cirrhosis are poorly known. This work was a prospective evaluation in two series of cirrhotic …

Escherichia coli has a rich history as biology's 'rock star', driving advances across many
fields. In the wild, E. coli resides innocuously in the gut of humans and animals but is also a …

EPIDEMIOLOGY AND PROGNOSIS OF SBP SBP is the most frequent bacterial infection in
cirrhosis, accounting for 10e30% of all reported bacterial infections in hospitalised patients …

Abstract (See the Editorial Commentary by Perez and Bonomo, on pages 175–7.)
Background. Extended-spectrum ß-lactamase–producing Escherichia coli (ESBL-EC) is an …

Background Studies on risk factors for carbapenem-resistant Klebsiella pneumoniae
(CRKP) infection have provided inconsistent results, partly due to the choice of the control …

Solid organ transplant (SOT) recipients are especially at risk of developing infections by
multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to …

Background Mortality related to bloodstream infections (BSIs) is high. The epidemiology of
BSIs is changing due to the increase in multidrug resistance, and it is unclear whether the …